STD Diagnostics Market Share, Size, Analysis, Growth, Trends and Forecasts to 2024 | Hexa Research6/29/2017 The global STD (sexually transmitted disease) Diagnostics Market is driven by growing awareness about STDs among the masses and greater governmental initiatives. Technological developments too play a vital role in fuelling market growth. Popularity of POC (point of care) testing propels the demand for improved products, such as diagnostic devices, kits, and reagents. A number of people have multiple sexual partners which in turn raises the possibility of contracting infections. Hence, there’s the growing need for accurate & precise diagnostics solutions.
The worldwide STD diagnostics market is segmented as per types of infections, location of tests, devices, and regions. On the basis of infections, the categories are human papilloma virus (HPV), syphilis, chlamydia, vaginitis, HIV (human immunodeficiency virus), herpes simplex virus, and gonorrhea. Chlamydia, gonorrhea, and syphilis are sexually transmitted infections (STIs) caused by bacteria. Browse Details of Report @ https://www.hexaresearch.com/research-report/std-diagnostics-market Genital warts, HPV, HIV, and hepatitis genital herpes are examples of STIs caused by viruses. These microorganisms get transmitted through semen, blood, and vaginal fluids. Chlamydia is by far the most commonly occurring sexually transmitted disease. In terms of revenues, this segment held the highest share in the overall industry. It generated revenues surpassing USD 36 billion in 2016. However, rising cases of syphilis may contribute to more than 20% of total industry revenues over the forecast period (2016 to 2024). Based on location of tests, the market is bifurcated into laboratory testing and point of care (PoC) testing. Laboratory tests are carried out either in public health labs or in private/commercial labs. Unlike, PoC testing solutions, laboratory tests deliver more precise results. PoC tests (such as test kits) are a more convenient option because these deliver immediate results, but they are not always accurate. The introduction of bedside & mobile testing is a step towards enhanced healthcare. The industry for bedside & mobile testing may expand at a CAGR nearly 10% from 2016 to 2024. According to type of device, the worldwide STD diagnostics market is segmented into thermal cyclers - PCRs, lateral flow readers, flow cytometers, differential light scattering machines, absorbance microplate reader, phone chips (microfluidics+ICT), and bench top/portable/rapid diagnostics kits. Portable/rapid diagnostics and phone chips are PoC testing devices, while the others are laboratory test devices. The thermal cyclers segment is anticipated to grow rapidly at a CAGR surpassing 8% during the forecast period. The portable PoC testing devices industry is propelled by continuous technological innovations. It may generate revenues exceeding USD 46 billion by 2024. Geographically, the global STD diagnostics market is divided into Asia Pacific, North America, Latin America, Europe, and the Middle East & Africa. Driven by surging public awareness about STIs and the presence of a well developed system of health insurance, North America dominates the global industry. Another vital factor that positively impacts this region is the growing accessibility to FDA-approved highly advanced testing devices. As per ongoing industry trends, Asia Pacific may register a high CAGR over the forecast period and thus prove to be a lucrative market in the long run. Prominent companies operating in the worldwide STD diagnostics market are Danaher Corporation, Abbott Laboratories, BioMerieux, Roche Holdings AG, and Becton Dickinson & Company. Recently, QuantuMDx, a U.K. based company dealing in life sciences diagnostics & tools, developed the Q-Poc. This is a highly affordable diagnostic DNA analyzer which is commonly known as the “handheld lab”. It is capable of diagnosing certain types of cancers and a number of infectious diseases (including the sexually transmitted ones). Equipped with a solar battery, the Q-Poc can analyze biological samples, for example, swabs are used to detect sexually transmitted diseases/infections. Browse Related Category Market Reports @ https://www.hexaresearch.com/research-category/clinical-diagnostics-industry About Us: Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives. Contact Us: Ryan Shaw Hexa Research Felton Office Plaza 6265 Highway 9 Felton, California 95018 United States Phone: +1-800-489-3075 Email: [email protected] Website - http://www.hexaresearch.com/ Visit our Blog: https://hexaresearchinc.wordpress.com/
0 Comments
Audiology Devices Market Share, Size, Analysis, Growth, Trends and Forecasts to 2024 | Hexa Research6/15/2017 Audiology devices are known to facilitate in treatment of hearing disorders such as congenital hearing and nerve deafness. It caters to three types of hearing loss viz., conductive, sensorineural, and mixed and grouped according to severity of deafness.
The Global Audiology Devices Market is estimated to grow at a 4.9% CAGR over the forecast phase (2016-2024). It would be worth around USD 10 billion by 2024. Technological advances of these devices as well as the increasing need by the elderly as well as those afflicted with hearing disorders will drive the market. The market is segmented by products and regions. Products of the audiology devices market encompass of diagnostic devices, cochlear implants, hearing aid, technological aid, and bone anchoring hearing aids (BAHA). Hearing aids are further divided into In-the-ear (ITE), Receiver-in-the-ear (RITE), canal hearing, and Behind-the-ear (BTE) aids. Canal hearing aids encompass completely-in-canal (CIC), in-the-canal (ITC) hearing, and invisible-in-canal aids. Major end-users of audiology devices are audiologists, service providers, and the healthcare sector. Browse Details of Report @ https://www.hexaresearch.com/research-report/audiology-devices-industry Hearing aids was the leading product of the market in 2015. It generated more than 60% revenue on account of its user-friendliness and high comfort. BTE aids had the largest share (55%) of the market in 2015. Cochlear implants are predicted to see major growth due to its effectiveness. Demand for canal hearing aids is projected to drive market demand in the coming years. Asia Pacific, Europe, North America, and RoW (Rest of the World) comprise as major geographical regions of the market. North America dominated the audiology devices market in 2015 owing to superior healthcare infrastructure and high disposable incomes. Europe accounted over 40% revenue shares in the same year. Asia Pacific is predicted to display a CAGR above 7% over the forecast period. Largely untapped markets in India and China will aid in market growth. Reputed global vendors of the audiology devices market are NHC/Amplifon, Duracell, Sophono (Medtronic), and Starkey Hearing Technologies. They employ strategies of mergers, acquisitions, alliances and partnerships in order to stay competitive. Main challenges faced by these players are lowered prices and increased shelf life of these products. A clear policy regarding fair trade practices can create new pathways. Browse Related Category Market Reports @ https://www.hexaresearch.com/research-category/medical-devices-industry About Us: Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives. Contact Us: Ryan Shaw Hexa Research Felton Office Plaza 6265 Highway 9 Felton, California 95018 United States Phone: +1-800-489-3075 Email: [email protected] Website - http://www.hexaresearch.com/ Visit Our Blog - https://hexaresearchinc.wordpress.com/ Global mHealth Market Analysis, Size, Share, Growth, Trends and Forecast to 2020 | Hexa Research6/14/2017 The Global mHealth Market is poised to expand at a whopping CAGR nearly 50% over the forecast period (2012 to 2020). mHealth or mobile health involves the use of wireless devices and mobiles to offer healthcare services. Despite considerable developments in the field of healthcare services, there are a number of issues that still persist pertaining to affordability and availability. Penetration of smartphones with 4G and 3G networks owing to urbanization & high income levels is expected to fuel the industry in the years to come.
3G & 4G LTE networks facilitate the prompt delivery of telemedicine services via speedy data transfers and video calls. High incidence of chronic diseases, such as diabetes, cancer, and heart ailments can contribute significantly to the global industry in the years to come. Various healthcare mobile applications may help patients in managing and controlling these ailments. However, infrastructural security and data privacy and safety may negatively impact overall demand during the forecast period. Browse Details of Report @ https://www.hexaresearch.com/research-report/mhealth-industry The worldwide mHealth market is segmented on the basis of services, participants, and geographies. According to services, the divisions are monitoring services, diagnosis services, healthcare systems strengthening services, and others. “Others” mainly pertains to wellness and prevention and thus focuses on geriatric care, smoking de-addiction, drug abuse prevention, healthy living, and child care. In 2013, monitoring services held more than 60% shares in the global market. Such services include independent aging solutions, post acute care services, devices (body trackers) for monitoring vital signs, and chronic disease management. Diagnosis services facilitate effective communications between patients and healthcare professionals about various health related issues. On the basis of participants, the industry is categorized into healthcare providers, content players, device vendors, and mobile operators. Being a rapidly expanding segment, mobile operators can continue dominating the global market over the forecast period. Beside connectivity services, they also offer end-to-end solutions, mobile telemedicine, content-based wellness information, and health call centers. This segment generates much of its revenues from monitoring & diagnostics services. Device vendors mainly refer to electronics & technology companies that offer equipment for gathering patient medical data and transmit data to back-end servers through mobile networks. Content players deal with information based services either through collaborations or in a stand-alone manner with mobile operators. Geographically, the global mHealth market is segmented into Asia Pacific, North America, Europe, and Rest of the World. With a market share (in revenue terms) exceeding 30%, North America led the global industry in 2013. Regional drivers are surging demand for monitoring services because of growing prevalence of chronic diseases & ailments worldwide. Asia Pacific can expand robustly at a more than 45% CAGR over the forecast period. The region is fueled by growing need for better healthcare services. Prominent companies operating in the global industry are Vodafone Group, Samsung Electronics, mQure, Orange, and Allscripts Healthcare Solutions among others. Kaiser Permanente and the Mayo Clinic’s venture capital unit supports an mHealth smoking cessation program that features an online communication & support platform and a wearable that releases drugs at equal time intervals. The concerned platform is undergoing clinical trials for both European and U.S. regulators. It may be available in the market in 2018 or 2019. Commonly known as the “Smartpatch”, this device releases biologically timed drugs. This action is based on the sensors that are present in the patch for measuring vital signs. Browse Related Category Market Reports @ https://www.hexaresearch.com/research-category/healthcare-industry About Us: Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives. Contact Us: Ryan Shaw Hexa Research Felton Office Plaza 6265 Highway 9 Felton, California 95018 United States Phone: +1-800-489-3075 Email: [email protected] Website - http://www.hexaresearch.com/ Visit Our Blog - https://hexaresearchinc.wordpress.com/ Atrial Fibrillation Market Analysis, Size, Share, Growth and Forecast to 2020 | Hexa Research6/13/2017 The Global Atrial Fibrillation Market is projected to reach nearly USD 16.2 billion by 2020. Growing geriatric population and rising cases of brain damage, atrial fibrillation, and strokes caused by blood clots are factors that propel the industry. People suffering from atrial fibrillation (AF) are given blood thinning & anti-clotting medicines. Based on the level of severity, this cardiovascular condition is of three types, namely, paroxysmal, persistent, and permanent. It is generally triggered by pulmonary embolus, hyperthyroidism, obesity, mitral stenosis, hypertension, and even pneumonia. People suffering from AF are five times more prone to strokes and blood clots as against those who are perfectly healthy.
High incidence of heart diseases and heart failures spurs demand for minimally invasive & atrial fibrillation procedures. Radiofrequency ablation is a commonly used procedure in young patients whose heart rhythms can be controlled neither with medicines nor with cardio version. Innovations in radiofrequency ablation, like remotely acquired computed tomography has contributed significantly to the overall industry. Another key driver is the ill effects of unhealthy lifestyle habits, such as smoking and drinking. Browse Details of Report@ https://www.hexaresearch.com/research-report/atrial-fibrillation-industry Procedures and regions are two key parameters based on which the global Atrial Fibrillation Market is segmented. According to the former, the industry is bifurcated into pharmacological drugs and non-pharmacological procedures. Pharmacological drugs are of two types, namely, anti arrhythmic and coagulant. Non-pharmacological procedures involve diagnosis using procedures, such as catheter ablation, maze surgery, and electric cardioversion. These procedures do not employ drugs of any sort. Besides lowering the chances of strokes, maze surgeries eliminate the need for life-long treatments based on anti-coagulants. Owing to high rate of success in treating arrhythmia, surgical catheter ablation holds the largest share in the global industry. There are a number of procedures in surgical catheter ablation. The extensively used ones are radiofrequency catheter ablation and microwave catheter ablation. Besides smaller cardiac incisions, these procedures ensure quick recoveries. Geographically, the worldwide Atrial Fibrillation Market is divided into Asia Pacific, North America, Europe, and Rest of the World. In terms of revenue, North America led the global industry in 2013. Regional drivers are a huge patient population inflicted by heart ailments, sophisticated medical infrastructure, and favorable reimbursement frameworks. Heightened awareness about non-pharmacological procedures is yet another prominent driver. It is however expected that Asia Pacific will expand robustly over the forecast period (2012 to 2020). The region is propelled by surging healthcare expenditure and widespread patient awareness. Prominent companies in the global atrial fibrillation market are Bristol Myers Squibb Corporation, Boehringer Ingelheim Gmbh, Sanofi Aventis, Boston Scientific Corporation, and Johnson & Johnson Ltd. Most market competitors focus greatly on innovations that enhance the efficiency of atrial fibrillation diagnostics. After almost of decade of in-depth research, researchers from Hospital Gregorio Marañón and the Polytechnic University of Valencia in Madrid have developed an effective treatment for AF. This system geolocates cardiac arrhythmias in real time. Such a feature guides doctors during cardiac ablations thereby reducing the duration & costs associated with surgical interventions for AF. This novel technology creates a map of the patient’s cardiac activity taking place in the two atria in real time. Browse Related Category Market Reports @ https://www.hexaresearch.com/research-category/medical-devices-industry About Us: Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives. Contact Us: Ryan Shaw Hexa Research Felton Office Plaza 6265 Highway 9 Felton, California 95018 United States Phone: +1-800-489-3075 Email: [email protected] Website - http://www.hexaresearch.com/ Visit Our Blog - https://hexaresearchinc.wordpress.com/ Tumor Ablation Market Share, Size, Analysis, Growth, Trends and Forecasts to 2022 | Hexa Research6/7/2017 The global Tumor Ablation Market is likely to obtain USD 1.5 billion at a compound annual growth rate (CAGR) of over 11% during the forecast phase (2015-2022). The major growth drivers influencing the market are the increasing occurrences of various types of cancers and the rising technical developments in the field of thermal ablation techniques.
The tumor ablation market is categorized as technologies, treatments, applications, and regions. Major technologies of the market are microwave, radiofrequency, cryoablation, and several other technologies including High-Intensity Focused Ultrasound (HIFU), radioiodine, laser ablation etc. Radiofrequency dominated the technology sector in 2015. However, the microwave ablation sector is likely to experience a huge growth (15%) in the near future. Enhanced efficiency along with minimum complications and process time (5 to 10 min.) is said to augment the segment growth. Browse Details of Report @ http://www.hexaresearch.com/research-report/tumor-ablation-market/ Laparoscopic, surgical, and percutaneous procedures are the various treatment procedures of the tumor ablation market. The surgical procedure sector held a large amount of market share (38.0%) in 2015. This can be attributed to open surgeries related to breast and liver cancer. However, the percutaneous procedure sector is said to experience a significant growth during 2015 to 2022 owing to the growing demands for minimally invasive procedures. The key applications of tumor ablation include several cancers such as breast, liver, prostate, lung, kidney, ENT cancer etc. The liver cancer sector held the largest share in 2015 and is further expected to grow during the forecast period. On the other hand, the lung cancer sector is expected to experience tremendous growth owing to the factors such as rising smoking incidences, air pollution and deskbound lifestyle. Geographically, the tumor ablation market is separated into Middle East & Africa, North America, Asia-Pacific (APAC), Europe, and Latin America. The North America region dominated the market with over 32% share in 2015. The APAC region is estimated to record the fastest CAGR over the forecast period. The improving healthcare infrastructures in APAC is said to spur market growth in this region in the coming years. The major participants of the tumor ablation market are Galil Medical Inc., HealthTronics, Angiodynamics, Boston Scientific Corporation, and SonaCare Medical. Browse Related Category Market Reports @ https://www.hexaresearch.com/research-category/medical-devices-industry About Us: Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives. Contact Us: Ryan Shaw Hexa Research Felton Office Plaza 6265 Highway 9 Felton, California 95018 United States Phone: +1-800-489-3075 Email: [email protected] Website - http://www.hexaresearch.com/ Visit our Blog: https://hexaresearchinc.wordpress.com/ The worldwide Glucose Biosensors Market size is expected to surpass USD 31 billion by 2024. It was valued about USD 15.3 billion in 2015. The high incidence of diabetes is a key factor that drives this market. Technological breakthroughs in monitoring glucose levels can spur market demand. Biosensors are devices that detect biological changes in the body and display those via electronic indicators. These changes (commonly known as analytes) could be gases, organic compounds, bacteria, and others.
Glucose biosensors can sense glucose levels within the body. They are small & minimally invasive devices that assess glucose levels in outpatient settings. Need for reliable biosensors still pose a market challenge. Alternative methods, like laboratory tests can restrict market growth. But several companies are investing in R&D (research and development) to improve the current technology. The global Glucose Biosensors Market is segmented on the basis of types, end-users, and regions. The two types are amprometric and fluorescent. Amperometric biosensors are extensively available. They function by way of glucose oxidase. These devices combine glucose with oxygen to produce hydrogen peroxide. The electrode identifies hydrogen peroxide and accurately measures glucose levels from it. Fluorescent biosensors are estimated to capture major market shares over the forecast period (2016-2024). These biosensors measure glucose levels by detecting sensitive proteins via the fluorescence process. Better operational life of these devices may benefit the market in the years ahead. Browse Details of Report@ https://www.hexaresearch.com/research-report/glucose-biosensors-market End-users are home care diagnostics, hospitals, and others. Others include diagnostic laboratories, research institutes, and clinical. Home care diagnostics held over 46% market shares in 2015. This segment comprises the adoption hand-held glucose meters. These devices deliver quick & efficient results and reduce the need for frequent hospital visits. ‘Hospitals’ may expand significantly over the next eight years. It could grow a 10.3% CAGR from 2015 to 2022. Regions in the global Glucose Biosensors Market are North America, Latin America, Middle East & Africa (MEA), Asia Pacific, and Europe. North America dominated the worldwide market with nearly 37% shares in 2015. Growing cases of diabetes coupled with technological advancements in the region can boost revenues during the forecast period. Europe may be the second largest market in terms of revenue after North America. Asia Pacific is expected to grow at a CAGR of 13% from 2015 to 2022. India & China jointly accounted for over 65% of the global diabetic base in 2013. This could benefit the worldwide market in the years ahead. Major players in the glucose biosensor industry are LifeScan Inc., Abbott Laboratories, F. Hoffmann-La Roche AG, and Bayer AG. These companies held over 70% of the total market shares in 2014. They focus on product development, partnerships, and collaborations for long term growth and market sustenance. For instance, LifeScan introduced a new glucose monitoring system, OneTouch Verio in 2015. It measures glucose levels via a color-coded indicator. Mayo Clinic, Gentag, NovioSense, and Fraunhofer Institute for Microelectronic Circuits & Systems entered a collaboration to fight against type 2 diabetes, in 2015. They aim at equipping smartphones with low-cost diabetes monitoring systems. The technology thus developed may be employed in a number of diabetes applications, such as eye sensors, skin patches, long-terms implantable sensors and so on. All of these devices can be controlled via smartphones. Currently, carbon nanotubes are gaining popularity due to their exceptional physical and electrical properties. These nanotubes work well with glucose biosensors by providing support for enzyme control. Browse Related Category Market Reports @ https://www.hexaresearch.com/research-category/clinical-diagnostics-industry About Us: Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives. Contact Us: Ryan Shaw Hexa Research Felton Office Plaza 6265 Highway 9 Felton, California 95018 United States Phone: +1-800-489-3075 Email: [email protected] Website - http://www.hexaresearch.com/ Visit our Blog: https://hexaresearchinc.wordpress.com/ RSV Diagnostics Market Share, Size, Analysis, Growth, Trends and Forecasts to 2024 | Hexa Research6/5/2017 The worldwide Respiratory Syncytial Virus Diagnostics Market is poised to grow at a CAGR exceeding 10% over the forecast period (2016 to 2024). It stood at USD 625 million in 2015. High prevalence of neonatal infections & viral diseases and the need for early RSV detection mechanisms for infants are key drivers of this industry. Respiratory syncytial virus harms the respiratory tract, the immune system, the heart, and lungs; thus leading to serious illnesses. It mainly affects infants in the age group of 0 to 11 months.
However, there are instances of people above the age of 60 years being afflicted by this virus. This is essentially because of weak immunity. Some patients may even need hospitalization. Clinical symptoms of the RSV infection can seldom be distinguished from the symptoms of other respiratory disorders. Hence, there is a pressing need to develop precise & accurate diagnostic solutions for such a disease. The global RSV Diagnostics market is categorized on the basis of products, end use, and regions. On the basis of products, the segments are DFA (direct fluorescence antibody) method, RADTs (rapid antigen diagnostic tests), flow cytometry, molecular diagnostics, gel microdroplets, diagnostic imaging, chromatographic immunoassay, and others. Due to high accuracy & precision, the molecular diagnostics segment may lead the overall industry during the forecast period. Browse Details of Report @ https://www.hexaresearch.com/research-report/respiratory-syncytial-virus-diagnostics-market Based on end uses, the industry is divided into clinics, hospitals, homecare, and laboratory. Hospitals held the largest share in 2015. It is expected that this segment will continue dominating the RSV Diagnostics market because of high hospitalization rate of RSV infected patients. “Homecare” too may expand significantly in the forthcoming years because of high demand for perinatal & in-house testing. Surging popularity of homecare services owes to high governmental investments in training programs for the same. Geographically, the global Respiratory Syncytial Virus Diagnostics Market is segmented into Latin America, Europe, North America, Asia Pacific, and the Middle East & Africa. With a market share surpassing 45%, North America led the industry in 2015. This region is propelled by high incidence of respiratory tract infections. Governmental initiatives, such as PAHO (Pan American Health Organization) may significantly contribute to market demand over the next couple of years. As per this initiative, it is absolutely necessary to rule out the possibilities of infections & metabolic defects in newborns. Asia Pacific may register a high growth rate from 2016 to 2024. High incidence of infectious diseases fueled by moderate to poor living conditions propels this regional market. Other factors that may drive this region are improved healthcare infrastructure, high R&D funding, favorable government mandates, and steady technological advancements. Prominent vendors in the worldwide industry are Thermo Fisher Scientific Inc.; Ortho Clinical Diagnostics; Abbott Laboratories; Roche Diagnostics; and Quest Diagnostics. In 2016, Luminex Corporation, a U.S. based biotechnology company received U.S. FDA (Food and Drug Administration) approval for its ARIES Flu A/B & RSV Assay. This device helps detect three main respiratory pathogens namely, RSV and influenza A & B viruses. It delivers results within two hours. Furthermore, it is equipped with a panel customization feature that gives it the ability to report the required results only. Browse Related Category Market Reports @ https://www.hexaresearch.com/research-category/clinical-diagnostics-industry About Us: Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives. Contact Us: Ryan Shaw Hexa Research Felton Office Plaza 6265 Highway 9 Felton, California 95018 United States Phone: +1-800-489-3075 Email: [email protected] Website - http://www.hexaresearch.com/ Visit our Blog: https://hexaresearchinc.wordpress.com/ |
Archives
October 2023
|